2025/07/11 by Finn Brokenshire, Kaleb Addy, John W. Pickering +4 · 1 voice
Medicine · #Acute Myocardial Infarction Research #Atrial Fibrillation Management and Outcomes #Venous Thromboembolism Diagnosis and Management
paper · pdf · doi:10.1111/1742-6723.70097
openalex publication_date 2025/07/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28
ABSTRACT Objective To assess the impact of two iterations of an emergency department (ED) atrial fibrillation (AF) pathway on anticoagulant prescribing. Methods Two quality improvement projects gave targeted anticoagulation guidance for AF. Anticoagulation prescription rates and related adverse events were monitored across four cohorts over 9 years (2014–2023). Results A total of 1425 patients were included. The proportion of patients discharged from ED on anticoagulation increased from 45% to 83%. Sixty‐day thromboembolic events, bleeding events and all‐cause mortality were unchanged. Conclusions Targeted anticoagulation guidance within an AF pathway improved adherence without raising adverse events.